Form 8-K - Current report:
SEC Accession No. 0000950170-24-118569
Filing Date
2024-10-30
Accepted
2024-10-30 06:15:39
Documents
34
Period of Report
2024-10-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lxeo-20241030.htm   iXBRL 8-K 44315
2 EX-99.1 lxeo-ex99_1.htm EX-99.1 36890
3 EX-99.2 lxeo-ex99_2.htm EX-99.2 26857
4 GRAPHIC img46940271_0.jpg GRAPHIC 249664
5 GRAPHIC lxeo-ex99_2s1.jpg GRAPHIC 272301
6 GRAPHIC lxeo-ex99_2s2.jpg GRAPHIC 548612
7 GRAPHIC lxeo-ex99_2s3.jpg GRAPHIC 363196
8 GRAPHIC lxeo-ex99_2s4.jpg GRAPHIC 462469
9 GRAPHIC lxeo-ex99_2s5.jpg GRAPHIC 345196
10 GRAPHIC lxeo-ex99_2s6.jpg GRAPHIC 475871
11 GRAPHIC lxeo-ex99_2s7.jpg GRAPHIC 324195
12 GRAPHIC lxeo-ex99_2s8.jpg GRAPHIC 465802
13 GRAPHIC lxeo-ex99_2s9.jpg GRAPHIC 478237
14 GRAPHIC lxeo-ex99_2s10.jpg GRAPHIC 370407
15 GRAPHIC lxeo-ex99_2s11.jpg GRAPHIC 311896
16 GRAPHIC lxeo-ex99_2s12.jpg GRAPHIC 313259
17 GRAPHIC lxeo-ex99_2s13.jpg GRAPHIC 418864
18 GRAPHIC lxeo-ex99_2s14.jpg GRAPHIC 308884
19 GRAPHIC lxeo-ex99_2s15.jpg GRAPHIC 445093
20 GRAPHIC lxeo-ex99_2s16.jpg GRAPHIC 313012
21 GRAPHIC lxeo-ex99_2s17.jpg GRAPHIC 274875
22 GRAPHIC lxeo-ex99_2s18.jpg GRAPHIC 423038
23 GRAPHIC lxeo-ex99_2s19.jpg GRAPHIC 477437
24 GRAPHIC lxeo-ex99_2s20.jpg GRAPHIC 148096
  Complete submission text file 0000950170-24-118569.txt   10972730

Data Files

Seq Description Document Type Size
25 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lxeo-20241030.xsd EX-101.SCH 25989
36 EXTRACTED XBRL INSTANCE DOCUMENT lxeo-20241030_htm.xml XML 4931
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41855 | Film No.: 241407263
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)